Direct‑Acting Oral Anticoagulants and Potential Inconsistencies with FDA‑Approved Dosing for Non‑valvular Atrial Fibrillation: A Retrospective Real‑World Analysis Across Nine US Healthcare Systems
本文未提供摘要，请点击“查看全文”查看完整内容。